The chemical and pharmaceutical equivalence of sulphadoxine/pyrimethamine tablets sold on the Tanzanian market

Journal of Clinical Pharmacy and Therapeutics

Volumn 30, Issue 6, 2005, Pages 575-581

  Hebron, Y ^a   Tettey, J N A ^a   Pournamdari, M ^a   Watson, D G ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Liquid chromatography mass spectrometry; Physical and chemical equivalence; Sulphadoxine pyrimethamine

Indexed keywords

FANSIDAR; FANSIMAX; LARIDOX; MALAREICH; MALOSTAT; MEDODOXINE; NOPYRIN; ORODAR; SULPHADAR; TANSIDAR; TANSIN; ANTIMALARIAL AGENT; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ARTICLE; ASSAY; BIOEQUIVALENCE; DRUG MARKETING; DRUG QUALITY; DRUG SOLUBILITY; HARDNESS; LIQUID CHROMATOGRAPHY; MARKET; MASS SPECTROMETRY; POSTMARKETING SURVEILLANCE; TABLET; TANZANIA; CHEMISTRY; COMPARATIVE STUDY; DRUG COMBINATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEDICAL LITERATURE; QUALITY CONTROL; SOLUBILITY; STANDARD; UNITED KINGDOM; UNITED STATES;

ANTIMALARIALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMBINATIONS; DRUG STABILITY; GREAT BRITAIN; HARDNESS; PHARMACOPOEIAS; PYRIMETHAMINE; QUALITY CONTROL; SOLUBILITY; SULFADOXINE; TABLETS; TANZANIA; UNITED STATES;

EID: 33644981138     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2005.00687.x     Document Type: Article

References (12)

1. Risha PG, Shewiyo D, Msami A, Masuki G, Vergote G, Vervaet C, Remon JP (2001) In vitro evaluation of essential drugs on the Tanzanian Market. Tropical Medicine and International Health, 7, 701 707.
2. Kayumba PC, Risha PG, Shewiyo D et al. (2004) The Quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania: influence of tropical storage conditions on in vitro dissolution. Journal of Clinical Pharmacy and Therapeutics, 29, 331 338.
3. Ballereau F, Prazuck T, Schrive I, Lafleuriel MT, Rozec D, Fisch A, Lafaix C (1997) Stability of essential drugs in the field: results of a study conducted over a two-year period in Burkina Faso. American Journal of Tropical Medicine and Hygiene, 57, 31 36.
4. Shakoor O, Taylor RB, Behrens RH (1997) Assessment of the incidence of substandard drugs in developing countries. Tropical Medicine and International Health, 2, 839 845.
5. Shakoor O, Taylor RB, Behrens RH et al. (2001) Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet, 35, 1933 1936.
6. Odeniyi MA, Adegoke OA, Adereti RB, Odeku OA, Itiola OA (2003) Comparative analysis of eight brands of sulfadoxine-pyrimethamine tablets. Tropical Journal of Pharmaceutical Research, 2, 161 167.
7. Minzi OM, Moshi MJ, Hipolite D, Massele AY, Tomson G, Ericsson O, Gustafsson L (2003) Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablet sold by private wholesale in Dar Es Salaam Tanzania. Journal of Clinical Pharmacology and Therapeutics, 28, 117 122.
8. United States Pharmacopoeia (1995 The National Formulary, USP23rd/NF18thedn., by authority of the United States Pharmacopoeial Convention Inc., Rockville, MA, USA : USP.
9. United States Food and Drug Administration (1997) ICH Guideline Q3B: Impurities in New Drug Products. Available at: http://www.fda.gov/cder/guidance/ 1317fnl.htm
10. Lachman L, Lieberman HA, Kanig JL (1986) Theory and practice of industrial pharmacy, 3rd edn. Philadelphia : Lea & Febiger, 299.
11. Gennaro AR (1995) Remington's pharmaceutical sciences, 19th edn. Easton, PA, USA : Mack Publishing Company, 1580 1583
12. Amin AA, Snow RW, Kokwaro GO (2005) The quality of sulfadoxine- pyrimethamine and amodiaquine products in the Kenyan retail sector. Journal of Clinical Pharmacology and Therapeutics, 30, 547 553.